Skip to main content

Moderna shares sink after leaked cancer data missed expectations

Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations

https://ift.tt/ukjrwAP

Comments

Popular posts from this blog